Authors:
WANDT H
FRANK M
EHNINGER G
SCHNEIDER C
BRACK N
DAOUD A
FACKLERSCHWALBE I
FISCHER J
GACKLE R
GEER T
HARMS P
LOFFLER B
OHL S
OTREMBA B
RAAB M
SCHONROCKNABULSI P
STROBEL G
WINTER R
LINK H
Citation: H. Wandt et al., SAFETY AND COST-EFFECTIVENESS OF A 10 X 10(9) L TRIGGER FOR PROPHYLACTIC PLATELET TRANSFUSIONS COMPARED WITH THE TRADITIONAL 20 X 10(9)/L TRIGGER - A PROSPECTIVE COMPARATIVE TRIAL IN 105 PATIENTS WITH ACUTE MYELOID-LEUKEMIA/, Blood, 91(10), 1998, pp. 3601-3606
Authors:
SCHNITTGER S
SCHOCH C
STREUBEL B
HINRICHS HF
OTREMBA B
PARWARESCH R
FONATSCH C
Citation: S. Schnittger et al., A CASE OF ATYPICAL MYELODYSPLASTIC SYNDROME WITH MICROMEGAKARYOCYTES,NORMAL PLATELET COUNT, AND T(3-12)(Q21-P13) WITH INV(3)(Q21Q26), Genes, chromosomes & cancer, 20(3), 1997, pp. 292-298
Authors:
LINK H
WANDT H
SCHONROCKNABULSI P
EHNINGER G
FRANKE A
GACKLE R
GEER T
STROBEL G
LINKESCH W
KRIEGER O
NIEDERWIESER D
NIKIFORAKIS E
OHL S
OTREMBA B
PITTERMANN E
SCHMIDT H
TISCHLER J
WEISS J
WILHELM M
BADRI N
Citation: H. Link et al., G-CSF (LENOGRASTIM) AFTER CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA - APLACEBO-CONTROLLED RANDOMIZED TRIAL, Experimental hematology, 25(8), 1997, pp. 35-35
Authors:
FREUND M
HEUSSNER P
HILD F
NOWAK R
GROTEMETKE A
DIEDRICH H
KOCH O
OTREMBA B
VONWUSSOW P
KLEINE HD
MERAN J
LINK H
HINRICHS HF
BALLEISEN L
FONATSCH C
POLIWODA H
Citation: M. Freund et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA - A DECADE OF EXPERIENCE, Medizinische Klinik, 91, 1996, pp. 18
Authors:
GRAMATZKI M
REPP R
DIEHL S
STROBEL G
WANDT H
LOFFLER B
BODENSTEIN H
SCHONROCK P
SCHLIMOK G
HEIDEMANN E
OTREMBA B
OHL S
SCHNEIDER C
EHNINGER G
LINK H
Citation: M. Gramatzki et al., IN AML IMMUNOPHENOTYPING IS IMPORTANT FOR DIAGNOSIS AND PROGNOSIS, Blood, 88(10), 1996, pp. 2230-2230
Authors:
LINK H
WANDT H
SCHONROCKNABULSI P
EHNINGER G
FRANKE A
GACKLE R
GEER T
STROBEL G
LINKESCH W
KRIEGER O
NIEDERWIESER D
NIKIFORAKIS E
OHL S
OTREMBA B
PITTERMANN E
SCHMIDT H
TISCHLER J
WEISS J
WILHELM M
BADRI N
Citation: H. Link et al., G-CSF (LENOGRASTIM) AFTER CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA - APLACEBO-CONTROLLED TRIAL, Blood, 88(10), 1996, pp. 2654-2654
Authors:
LINK H
EHNINGER G",SCHONROCKNABULSI,GRAMATZKI,"FRANKE A
EINSELE H
TISCHLER J
BRACK N
OTREMBA B
LUTZ M
GACKLE R
OHL S
HEIDEMANN E
WILHELM M
LOFFLER B
WEISS J
GEER T
DIEHL S
WANDT H
Citation: H. Link et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION COMPARED WITH HIGH-DOSE ARA-C POSTREMISSION THERAPY IN ACUTE MYELOID-LEUKEMIA, Blood, 88(10), 1996, pp. 2723-2723
Authors:
FREUND M
HILD F
GROTEMETKE A
NOWAK R
OTREMBA B
WORMANN B
KOCH O
DOHMEN M
KLEINE HD
LINK H
HIDDEMANN W
HINRICHS F
BALLEISEN L
FONATSCH C
POLIWODA H
Citation: M. Freund et al., COMBINATION OF CHEMOTHERAPY AND INTERFERON ALFA-2B IN THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA, Seminars in hematology, 30(3), 1993, pp. 11-13